Back to Search Start Over

Cases in the management of prostate cancer: the addition of darolutamide to androgen deprivation therapy and docetaxel in a 55-year-old man with metastatic hormone-sensitive prostate cancer

Authors :
E David, Crawford
Source :
Clinical advances in hematologyoncology : HO. 20(7)
Publication Year :
2022

Subjects

Subjects :
Male
Prostatic Neoplasms, Castration-Resistant
Androgens
Humans
Prostatic Neoplasms
Pyrazoles
Androgen Antagonists
Docetaxel
Middle Aged

Details

ISSN :
15430790
Volume :
20
Issue :
7
Database :
OpenAIRE
Journal :
Clinical advances in hematologyoncology : HO
Accession number :
edsair.pmid..........fb811e2d418ebb46713dc976e2b77b44

Tools

Authors Abstract Subjects Details